Recurrent Malignant Testicular Germ Cell Tumor Recruiting Phase 2 Trials for Palbociclib (DB09073)

IndicationStatusPhase
DBCOND0028803 (Recurrent Malignant Testicular Germ Cell Tumor)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01037790PHASE II TRIAL OF THE CYCLIN-DEPEDENT KINASE INHIBITOR PD 0332991 IN PATIENTS WITH CANCERTreatment